Agnès Bernet, (born 1968) is a French cell biologist and professor of cancer biology at the University Claude Bernard Lyon I.
Her research focused on the study of two regions that may be involved in the activation of human alpha globin genes during erythroid differentiation.
[2] In 2008, she co-founded the company Netris Pharma SAS, where she serves as scientific director and coordinates numerous research projects concerning clinical therapies relating to cancer.
In particular, her work on Netrin-1, the antibody developed by her team, is an antitumor product that has been tested in humans in clinical trials at the Center Léon Bérard.
[5] In 2015, she received the Irène Joliot-Curie Prize in the Women and Business category for her work in both teaching and researching cancer therapies.